FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $563,000 | +98.2% | 14,941 | -10.6% | 0.00% | 0.0% |
| Q4 2020 | $284,000 | +255.0% | 16,721 | -1.5% | 0.00% | – |
| Q3 2020 | $80,000 | -23.1% | 16,971 | 0.0% | 0.00% | – |
| Q2 2020 | $104,000 | +166.7% | 16,971 | 0.0% | 0.00% | – |
| Q1 2020 | $39,000 | -50.6% | 16,971 | -1.5% | 0.00% | – |
| Q4 2019 | $79,000 | +17.9% | 17,221 | 0.0% | 0.00% | – |
| Q3 2019 | $67,000 | -35.6% | 17,221 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | -55.0% | 17,221 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $231,000 | +44.4% | 17,221 | 0.0% | 0.00% | – |
| Q4 2018 | $160,000 | -33.3% | 17,221 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $240,000 | -11.8% | 17,221 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $272,000 | -4.6% | 17,221 | +3.9% | 0.00% | 0.0% |
| Q1 2018 | $285,000 | -21.5% | 16,571 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $363,000 | -45.5% | 16,571 | +1.7% | 0.00% | -50.0% |
| Q3 2017 | $666,000 | +35.6% | 16,291 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $491,000 | -14.9% | 16,291 | +2.1% | 0.00% | -50.0% |
| Q1 2017 | $577,000 | -70.4% | 15,957 | -59.0% | 0.00% | -66.7% |
| Q4 2016 | $1,950,000 | -8.4% | 38,924 | -4.0% | 0.01% | -14.3% |
| Q3 2016 | $2,129,000 | +88.1% | 40,565 | +48.2% | 0.01% | +75.0% |
| Q2 2016 | $1,132,000 | +83.8% | 27,374 | +80.7% | 0.00% | +100.0% |
| Q1 2016 | $616,000 | -2.1% | 15,152 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $629,000 | +170.0% | 15,152 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $233,000 | -38.0% | 15,152 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $376,000 | +37.7% | 15,152 | +27.0% | 0.00% | 0.0% |
| Q1 2015 | $273,000 | -10.5% | 11,933 | +5.7% | 0.00% | 0.0% |
| Q4 2014 | $305,000 | +131.1% | 11,293 | 0.0% | 0.00% | – |
| Q3 2014 | $132,000 | -25.0% | 11,293 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $176,000 | – | 11,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|